|
Pharmaceutical companies, hospitals, advocacy groups and others with a stake in health reform continue to lobby in hopes of winning concessions in the overhaul, or at least surviving the changes unscathed. "One of the groups key to working any deal is the pharmaceutical industry, which has been quite active behind the scenes," National Public Radio reports. NPR interviewed former congressman Billy Tauzin, who is president of PhRMA, the drug industry"s lobbying
group. Tauzin said he couldn"t predict whether health reform, which his group supports, would make the industry wealthier, but added, "we"ll do okay" (7/30). Meanwhile, one Texas hospital has aggressively pursued a lobbying and fundraising campaign to encourage lawmakers to "soften measures that could choke its rapid growth," the New York Times reports.
|